| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -50K | 100% | $10.06 | -$503K |
| Net | -1 | -50K | -100% | -$503K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Wayne P. Rothbaum | Director | $258M | Mar 1, 2024 | ||
| Merrill A. Mcpeak | Director | $5.66M | Mar 1, 2024 | ||
| Frederick G. Vogt | Interim CEO & General Counsel, Director | $2.17M | Mar 5, 2025 | ||
| Iain D. Dukes | Director | $1.32M | Jun 11, 2024 | ||
| Friedrich Graf | Chief Medical Officer | $754K | Mar 5, 2025 | ||
| Igor Bilinsky | Chief Operating Officer | $733K | Mar 5, 2025 | ||
| Raj K. Puri | Chief Regulatory Officer | $722K | Mar 14, 2025 | ||
| Daniel Gordon Kirby | Chief Commercial Officer | $707K | Feb 10, 2025 | ||
| Jean-Marc Bellemin | Chief Financial Officer | $606K | Mar 5, 2025 | ||
| Ryan Maynard | Director | $488K | -$503K | -50.8% | Nov 12, 2024 |
| Wendy L. Dixon | Director | $469K | Jun 10, 2022 | ||
| Michael Weiser | Director | $413K | Jun 11, 2024 | ||
| Wendy L. Yarno | Director | $413K | Jun 11, 2024 | ||
| Athena Countouriotis | Director | $413K | Jun 11, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|